·114·中国现代药物应用2024年1月第18卷第2期ChinJModDrugAppl,Jan2024,Vol.18,No.2连花清瘟颗粒治疗流行性感冒的效果分析宋佳【摘要】目的研究连花清瘟颗粒治疗流行性感冒的临床疗效。方法370例流行性感冒患者,按治疗方法不同分为对照组(182例)和观察组(188例)。对照组患者给予磷酸奥司他韦颗粒进行治疗,观察组患者给予连花清瘟颗粒进行治疗。比较两组患者的临床疗效、不良反应发生率及症状恢复时间。结果观察组(90.43%)的临床总有效率明显高于对照组(80.77%),差异有统计学意义(P<0.05)。观察组(6.38%)和对照组(5.49%)的不良反应发生率差异不显著(P>0.05)。观察组的体温恢复正常时间(3.51±0.69)d、鼻塞消失时间(3.40±0.66)d、咳嗽消失时间(3.31±0.65)d、乏力恢复正常时间(3.47±0.68)d明显比对照组的(3.72±0.71)、(3.57±0.68)、(3.45±0.66)、(3.69±0.70)d短,差异有统计学意义(P<0.05)。结论连花清瘟颗粒治疗流行性感冒患者效果显著,可明显缩短患者临床症状恢复时间,且用药安全,值得推荐。【关键词】连花清瘟颗粒；流行性感冒；磷酸奥司他韦颗粒DOI：10.14164/j.cnki.cn11-5581/r.2024.02.030AnalysisontheeffectofLianhuaQingwenGranulesintreatinginfluenzaSONGJia.ChangtuCountyCentralHospital,Tieling112599,China【Abstract】ObjectiveTostudytheclinicalefficacyofLianhuaQingwenGranulesintreatinginfluenza.Methods370patientswithinfluenzaweredividedintoacontrolgroup(182cases)andanobservationgroup(188cases)accordingtodifferenttreatmentmethods.Thecontrolgroupwastreatedwithoseltamivirphosphategranules,andtheobservationgroupwastreatedwithLianhuaQingwenGranules.Theclinicalefficacy,incidenceofadversereactionsandrecoverytimeofsymptomswerecomparedbetweenthetwogroups.ResultsThetotalclinicaleffectiverateoftheobservationgroup(90.43%)wassignificantlyhigherthanthatofthecontrolgroup(80.77%),andthedifferencewasstatisticallysignificant(P<0.05).Therewasnosignificantdifferenceintheincidenceofadversereactionsbetweentheobservationgroup(6.38%)andthecontrolgroup(5.49%)(P>0.05).Intheobservationgroup,thetimeofbodytemperaturereturnedtonormalwas(3.51±0.69)d,thedisappearancetimeofnasalcongestionwas(3.40±0.66)d,thecoughdisappearancetimewas(3.31±0.65)dandthefatiguerecoveryti...
